INTS vs LULU · $7.7M cap vs P/E 17, rev $10.59B
Intensity Therapeutics, Inc. Common stock (INTS) versus Lululemon Athletica Inc. (LULU) — a side-by-side from cached financials, not a winner call.
Intensity Therapeutics, Inc. Common stock (INTS) is a biotechnology company listed on US.
Lululemon Athletica Inc. (LULU) is a apparel retail company listed on US. It is led by Calvin McDonald.
INTS does not have a complete income-statement cache yet.
Latest reported LULU revenue for 2025-02-02 was $10.59B. Net income was $1.81B. Revenue was up 10.1% from 2024-01-28 to 2025-02-02. LULU currently screens at market cap $29.68B and trailing P/E 16.8.
INTS currently screens at market cap $7.7M. LULU currently screens at market cap $29.68B and trailing P/E 16.8.
Not investment advice. Open the INTS and LULU stock pages for the full models.
Not investment advice.